Medical technology company RaySearch Laboratories AB (STO:RAYB) and Vision RT, two leading companies in the radiation oncology space, on Monday announced a strategic partnership, to work together on technology development projects.

Details of these developments are currently confidential.

However, the intention of both the companies is to deliver both improved integration and entirely new capabilities to radiation oncology professionals, to help enhance workflow and improve clinical decision-making.

Also, Vision RT and RaySearch make natural partners as their activities are very complementary, while they are both highly focused on innovative customers looking to deliver high quality care in the radiation oncology space.

Vision RT said it defines the standard of care in Surface Guided Radiation Therapy. It provides superior solutions for the radiotherapy market, with products installed in many of the leading treatment centres in the world. It is part of the William Demant Invest (WDI) family, a leading Danish Medtech investor with a long-term investment perspective.

RaySearch develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare, the next-generation oncology information system.